NRX Pharmaceuticals, Inc. (NRXP) Net income 2018–2025
NRX Pharmaceuticals, Inc. (NRXP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$28.6MFY2025 · since FY2018: $66,101 → -$28.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.6M | -13.9% |
| FY2024 | -$25.1M | +16.7% |
| FY2023 | -$30.1M | +24.2% |
| FY2022 | -$39.8M | +57.3% |
| FY2021 | -$93.1M | -79.7% |
| FY2020 | -$51.8M | -12777.2% |
| FY2019 | $408,427 | +517.9% |
| FY2018 | $66,101 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRXP financial trends
NRXP RevenueNRXP Net marginNRXP Gross profitNRXP Gross marginNRXP Operating incomeNRXP Operating marginNRXP Operating cash flowNRXP Free cash flowNRXP Capital expendituresNRXP Return on equityNRXP Stock buybacksNRXP Dividends paidNRXP Total assetsNRXP Total liabilitiesNRXP Shareholders’ equityNRXP overview →